<font color="blue">Protection_1</font> of man from <font color="blue">natural_1</font> <font color="blue">infection_1</font> <font color="blue">with_1</font> <font color="blue">influenza_1</font> <font color="blue">A2_1</font> Hong Kong virus by amantadine : a controlled field trial . 
<br>
<br> <font color="blue">Prophylactic_1</font> <font color="blue">administration_1</font> <font color="blue">of_1</font> <font color="blue">amantadine_1</font> <font color="blue">in_1</font> <font color="blue">doses_1</font> <font color="blue">of_1</font> <font color="blue">100_1</font> <font color="blue">mg_1</font> <font color="blue">._1</font> <font color="blue">twice_1</font> <font color="blue">a_1</font> <font color="blue">day_1</font> <font color="blue">offered_1</font> <font color="blue">statistically_1</font> <font color="blue">significant_1</font> <font color="blue">protection_3</font> <font color="blue">against_3</font> <font color="blue">influenza_3</font> <font color="blue">A2_3</font> <font color="blue">infection_3</font> in a double - blind field trial involving 391 medical student volunteers during the influenza A2 Hong Kong epidemic in Helsinki in the winter of 1969 . <font color="blue">Serologically_3</font> <font color="blue">verified_3</font> <font color="blue">influenza_3</font> <font color="blue">,_3</font> <font color="blue">as_1</font> <font color="blue">measured_1</font> <font color="blue">by_1</font> <font color="blue">complement_3</font> <font color="blue">fixation_3</font> <font color="blue">and/or_3</font> <font color="blue">haemagglutination_3</font> <font color="blue">inhibition_3</font> <font color="blue">,_3</font> <font color="blue">occurred_1</font> in 27 out of 192 students in the amantadine group against 57 out of 199 in the placebo group , giving a protection rate of 52% .